July 2010

A Call to Action: Addressing the Challenge of Artemisinin-resistant Malaria

A recent editorial by MEG member Larry Slutsker and colleagues from the United States Centers for Disease Control and Prevention (CDC) draws attention to recent reports from Southeast Asia that shows early signs of resistance to artemisinin-based combination therapies (ACTs). Authors highlight the urgent need to eliminate ACT-resistant malaria before it spreads to other parts of the world, namely sub-Saharan Africa, which would be detrimental to the impressive progress the continent has made in reducing its malaria burden.

A Call to Action: Addressing the Challenge of Artemisinin-resistant Malaria